Literature DB >> 29221347

Safe administration of intrapleural alteplase during pregnancy.

Heather Torbic1, Hanine Inaty1, Siva Raja1, Humberto Choi1.   

Abstract

Instillation of intrapleural (IP) fibrinolytics has been used in patients with complicated parapneumonic pleural effusions to improve fluid drainage and decrease the need for surgical intervention. However, clinical trials have not included certain special populations such as pregnant females and there are currently no published case reports of this practice in this group. We describe the case of a 35-year-old female, G2P1 at 32 weeks of gestation, with a complicated pleural effusion due to influenza pneumonia with superimposed bacterial pneumonia. Her parapneumonic pleural effusion was successfully treated with intercostal tube drainage and IP alteplase [tissue plasminogen activator (tPA)] administration and systemic antibiotics with no harm to her or her fetus, sparing this patient from more invasive surgical procedures. This is the first reported case of successful IP tPA administration for a complicated parapneumonic pleural effusion in a pregnant patient.

Entities:  

Keywords:  Alteplase; intrapleural; pleural effusion; pregnancy

Year:  2017        PMID: 29221347      PMCID: PMC5708495          DOI: 10.21037/jtd.2017.07.114

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


  16 in total

1.  Intrapleural fibrinolytic agents for empyema and complicated parapneumonic effusions: a meta-analysis.

Authors:  Yasuharu Tokuda; Dai Matsushima; Gerald H Stein; Seishirou Miyagi
Journal:  Chest       Date:  2006-03       Impact factor: 9.410

Review 2.  Efficacy of intrapleural instillation of fibrinolytics for treating pleural empyema and parapneumonic effusion: a meta-analysis of randomized control trials.

Authors:  Wencheng Nie; Yanru Liu; Jian Ye; Liuhong Shi; Fangchun Shao; Kejing Ying; Ruifeng Zhang
Journal:  Clin Respir J       Date:  2014-01-16       Impact factor: 2.570

Review 3.  Thrombolytic therapy for ischemic stroke secondary to paradoxical embolism in pregnancy: a case report and literature review.

Authors:  Yuebing Li; John Margraf; Bryan Kluck; Donna Jenny; John Castaldo
Journal:  Neurologist       Date:  2012-01       Impact factor: 1.398

4.  Randomised controlled trial of intrapleural streptokinase in community acquired pleural infection.

Authors:  R J Davies; Z C Traill; F V Gleeson
Journal:  Thorax       Date:  1997-05       Impact factor: 9.139

5.  Predictors of outcome and long-term survival in patients with pleural infection.

Authors:  C W Davies; S E Kearney; F V Gleeson; R J Davies
Journal:  Am J Respir Crit Care Med       Date:  1999-11       Impact factor: 21.405

6.  The diagnosis and management of pleural effusions in the ICU.

Authors:  David M Maslove; Benson Tze-Ming Chen; Helena Wang; Ware G Kuschner
Journal:  J Intensive Care Med       Date:  2011-11-11       Impact factor: 3.510

7.  Diagnosis and management of parapneumonic effusions and empyema.

Authors:  Steve A Sahn
Journal:  Clin Infect Dis       Date:  2007-10-24       Impact factor: 9.079

8.  Intrapleural use of tissue plasminogen activator and DNase in pleural infection.

Authors:  Najib M Rahman; Nicholas A Maskell; Alex West; Richard Teoh; Anthony Arnold; Carolyn Mackinlay; Daniel Peckham; Chris W H Davies; Nabeel Ali; William Kinnear; Andrew Bentley; Brennan C Kahan; John M Wrightson; Helen E Davies; Clare E Hooper; Y C Gary Lee; Emma L Hedley; Nicky Crosthwaite; Louise Choo; Emma J Helm; Fergus V Gleeson; Andrew J Nunn; Robert J O Davies
Journal:  N Engl J Med       Date:  2011-08-11       Impact factor: 91.245

9.  U.K. Controlled trial of intrapleural streptokinase for pleural infection.

Authors:  Nicholas A Maskell; Christopher W H Davies; Andrew J Nunn; Emma L Hedley; Fergus V Gleeson; Robert Miller; Rhian Gabe; Glyn L Rees; Timothy E A Peto; Mark A Woodhead; Donald J Lane; Janet H Darbyshire; Robert J O Davies
Journal:  N Engl J Med       Date:  2005-03-03       Impact factor: 91.245

Review 10.  Neuroendocrinal, Neurodevelopmental, and Embryotoxic Effects of Recombinant Tissue Plasminogen Activator Treatment for Pregnant Women with Acute Ischemic Stroke.

Authors:  Anna Steinberg; Tiago P Moreira
Journal:  Front Neurosci       Date:  2016-02-25       Impact factor: 4.677

View more
  1 in total

Review 1.  From Bedside to the Bench-A Call for Novel Approaches to Prognostic Evaluation and Treatment of Empyema.

Authors:  Sophia Karandashova; Galina Florova; Steven Idell; Andrey A Komissarov
Journal:  Front Pharmacol       Date:  2022-01-20       Impact factor: 5.810

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.